CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 26 enrolled
Drug / intervention
probiotics +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04322500
NCT04322500N/ACompleted
CompareCT.gov

Intestinal Microbiota: a New Target for Chalaziosis Treatment in Children

University of Molise·interventional·Posted Mar 26, 2020·Updated May 5, 2020

In Brief

A clinical study evaluating probiotics and conservative treatment for Chalazion. Completed, enrolled 26 participants across 1 site.

Detailed Summary

There is growing evidence encouraging the use of probiotics in many conditions in children. The aim of the investigator's study is to define the possible beneficial impact of probiotics on paediatric patients affected by chalaziosis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChalazion
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 26, 2020
Enrollment StartFeb 1, 2019
Primary CompletionFeb 29, 2020
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 6.3 years ago

Interventions

probioticsdietary

use specific probiotics in addiction to conservative treatment to modify the intestinal microbiome to ameliorate the clinical course of chalaziosis in children by re-establishing intestinal and immune homeostasis

conservative treatmentother

lid hygiene, warm compression, and dexamethasone/tobramycin ointment for at least 20 days